Growth in the cardiac safety services market is mainly received from % several key factors, which include various government statistics. In the first place, there is an increase in the incidence of cardiovascular diseases. CVDs are the number one cause of death globally: more people die annually from CVDs than from any other cause; an estimated 17.9 million percent, account for three-quarters of all deaths due to non-communicable diseases as per the World Health Organization. This distressing figure illustrates the necessity for comprehensive cardiac safety solutions that both clinical trials, as well as everyday healthcare, can utilize to keep track of and tackle risks at an early stage.